The Olam
Red Sea Routing Risk
The Olam Editorial Team
Jun 9, 2026, 9:02 AM EDT

Red Sea routing risk is the structural shipping disruption introduced by the Houthi attack campaign against commercial vessels in the Red Sea and Bab el-Mandeb strait beginning in late 2023. The disruption functionally suspended Israel's Eilat port commercially and forced container lines to reroute around the Cape of Good Hope, adding 10-14 days transit time and approximately $1 million per voyage in cost.

At its worst, Suez Canal traffic fell 50-60%. War-risk insurance premiums spiked by orders of magnitude. Israeli importers permanently extended inventory buffers. Egypt lost approximately $7 billion in 2024 Suez Canal revenue.

The operational concept is now structurally embedded in Mediterranean-Asia trade modeling. Full coverage: Red Sea Shipping Disruption and the Impact on Israeli Supply Chains.

Israeli AI Companies & Infrastructure

All coverage →
Magic Software: The 35-Year Nasdaq Veteran
Israeli AI Companies & Infrastructure · Sep 17, 2026, 9:00 AM EDT
Magic Software: The 35-Year Nasdaq Veteran

Magic Software Enterprises (formerly Nasdaq/TASE: MGIC). Founded 1983 in Or Yehuda by David Assia and Yaki Dunietz. Enterprise app-dev platf…

WalkMe: The SAP $1.5B Acquisition
Israeli AI Companies & Infrastructure · Sep 16, 2026, 2:00 AM EDT
WalkMe: The SAP $1.5B Acquisition

WalkMe (formerly Nasdaq: WKME). Founded 2011 in Tel Aviv by Dan Adika, Rafael Sweary, Eyal Cohen. Digital adoption platform. Acquired by SAP…

The Kosher Economy

All coverage →
The Kosher Price Premium
The Kosher Economy · Sep 16, 2026, 5:00 AM EDT
The Kosher Price Premium

Kosher meat costs roughly double. Packaged goods carry a 7–30% premium. Passover staples spike every spring. The price of keeping kosher in…

The Kosher Economy: The Olam Guide
The Kosher Economy · Sep 13, 2026, 1:44 AM EDT
The Kosher Economy: The Olam Guide

The kosher economy runs $400B+ in certified product value, a Big Five of competing certifiers, and a global restaurant and grocery scene fro…

Health & Biotech

All coverage →
Who Owns Teva Pharmaceutical?
Health & Biotech · Sep 22, 2026, 5:00 AM EDT
Who Owns Teva Pharmaceutical?

The world's largest generic drugmaker has no controlling shareholder at all — a structure that traces back to the 1980s, decades before Beze…

Beilinson Hospital: Clalit's Transplant Leader
Health & Biotech · Sep 10, 2026, 5:00 AM EDT
Beilinson Hospital: Clalit's Transplant Leader

Clalit's Petah Tikva tertiary flagship (Rabin Medical Center) and Israel's #1 transplant center. Top-tier in the hospitals Answer Index — ev…